94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Front. Bioeng. Biotechnol.
Sec. Nanobiotechnology
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1565999
This article is part of the Research Topic The Road toward Nano-Based Diagnostics for Health and Disease View all 7 articles
Advances in Nanomedicine and Delivery Systems for Gastric Cancer Research
Provisionally accepted
Sizhe Wang 1
Jilei Li 2
Zhenyu Zhang 1 Shasha Cao 1 Zihan Zhang 1 Yifan Bian 1 Yanchao Xu 2 Chunzheng Ma 2*- 1 Henan Academy of Chinese Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, China
- 2 Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, Henan Province, China
The early diagnosis rate of gastric cancer is low, and most patients are already at an ad vanced stage by the time they are diagnosed, posing significant challenges for treatment and exhibiting high recurrence rates, which notably diminish patients' survival time and quality of life. Therefore, there is an urgent need to identify methods that can enhance treatment effic acy. Nanomedicine, distinguished by its small size, high targeting specificity, and strong biolo gical compatibility, is particularly well-suited to address the toxic side effects associated with current diagnostic and therapeutic approaches for gastric cancer. Consequently, the application of nanomedicine and delivery systems in the diagnosis and treatment of gastric cancer has ga rnered increasing interest from researchers. This review provides an overview of recent advan cements in the use of nanomaterials as drugs or drug delivery systems in gastric cancer rese arch, encompassing their applications in diagnosis, chemotherapy, radiotherapy, surgery, and p hototherapy, and explores the promising prospects of nanomedicine in the treatment of gastric cancer.
Keywords: gastric cancer, Nanomedicine, nanomaterials, Nano drug delivery systems, D iagnosis and treatment
Received: 24 Jan 2025; Accepted: 05 Mar 2025.
Copyright: © 2025 Wang, Li, Zhang, Cao, Zhang, Bian, Xu and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Chunzheng Ma, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, Henan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.